Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AMY ELIZABETH ROBERTS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1003894775
CMS profile
272479
Location
TOWN AND COUNTRY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$497.46

33 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $497.46 33

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AMY ELIZABETH ROBERTS

NPI 1003894775 · CMS profile ID 272479

Allopathic & Osteopathic Physicians / Family Medicine

TOWN AND COUNTRY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1003894775?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AMY ELIZABETH ROBERTS, NPI 1003894775, CMS profile ID 272479. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1003894775?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). AMY ELIZABETH ROBERTS, NPI 1003894775, CMS profile ID 272479. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1003894775?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
AMY ELIZABETH ROBERTS, NPI 1003894775, CMS profile ID 272479, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–33 of 33 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1003894775?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

33 matching records · $497.46 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 33 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–33 of 33.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $19.4112/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727837585 CMS
Merck Sharp & Dohme Corporation $18.1512/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747824443 CMS
Lilly USA, LLC $12.2312/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728329065 CMS
Novo Nordisk Inc $15.5012/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745005759 CMS
Amarin Pharma Inc. $12.8211/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739783573 CMS
Lilly USA, LLC $14.2311/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728328143 CMS
PFIZER INC. $16.2611/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743539833 CMS
Amarin Pharma Inc. $14.0811/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739777833 CMS
PFIZER INC. $16.1111/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743482383 CMS
Janssen Pharmaceuticals, Inc $13.0811/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718982245 CMS
Novo Nordisk Inc $11.6910/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744945161 CMS
Amarin Pharma Inc. $12.4210/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739784763 CMS
Amarin Pharma Inc. $18.7510/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739777839 CMS
E.R. Squibb & Sons, L.L.C. $16.1110/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727837549 CMS
Lilly USA, LLC $11.0810/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728352403 CMS
Merck Sharp & Dohme Corporation $18.5510/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747764001 CMS
Lilly USA, LLC $16.6509/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728352405 CMS
Amarin Pharma Inc. $13.3809/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739784768 CMS
Allergan, Inc. $24.3709/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723677671 CMS
Janssen Pharmaceuticals, Inc $16.8409/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718982239 CMS
Novo Nordisk Inc $11.4808/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744833169 CMS
Lilly USA, LLC $12.5708/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728352399 CMS
Novo Nordisk Inc $15.3708/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744989499 CMS
PFIZER INC. $18.4407/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743264383 CMS
Novo Nordisk Inc $13.0706/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744758815 CMS
Novo Nordisk Inc $21.0305/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744777279 CMS
Novo Nordisk Inc $14.1605/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744713441 CMS
Novo Nordisk Inc $14.6503/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744655431 CMS
Novo Nordisk Inc $11.5402/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744614739 CMS
PFIZER INC. $15.0502/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743390127 CMS
Novo Nordisk Inc $10.7102/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744594483 CMS
AstraZeneca Pharmaceuticals LP $12.6301/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736103803 CMS
PFIZER INC. $15.0501/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743399513 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $625.85 43
PY2020 $497.46 33
PY2021 $585.99 36
PY2022 $4,463.39 11
PY2023 $209.74 9
PY2024 $900.78 10
PY2025 $221.61 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $659,355.35 57
PY2024 Principal investigator $1,673,854.87 52
PY2023 Principal investigator $1,696,177.01 1,469

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

57 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ModernaTX, Inc. $5,443.06 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947378
Principal investigator 1 ModernaTX, Inc. $12,648.00 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947380
Principal investigator 1 ModernaTX, Inc. $3,129.98 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947388
Principal investigator 1 ModernaTX, Inc. $44,900.43 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947390
Principal investigator 1 ModernaTX, Inc. $4,879.80 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947394
Principal investigator 1 ModernaTX, Inc. $3,468.64 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947398
Principal investigator 1 ModernaTX, Inc. $612.81 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947400
Principal investigator 1 ModernaTX, Inc. $3,373.44 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947410
Principal investigator 1 ModernaTX, Inc. $5,999.52 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947412
Principal investigator 1 ModernaTX, Inc. $545.60 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947416
Principal investigator 1 ModernaTX, Inc. $625.44 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947422
Principal investigator 1 ModernaTX, Inc. $899.00 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947424
Principal investigator 1 ModernaTX, Inc. $4.41 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947426
Principal investigator 1 ModernaTX, Inc. $12,813.71 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947430
Principal investigator 1 ModernaTX, Inc. $5,529.57 11/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947432
Principal investigator 1 ModernaTX, Inc. $750.00 10/22/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947382
Principal investigator 1 ModernaTX, Inc. $1,800.00 10/22/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947386
Principal investigator 1 ModernaTX, Inc. $2,000.00 10/22/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947414
Principal investigator 1 ModernaTX, Inc. $150.00 10/13/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002669
Principal investigator 1 ModernaTX, Inc. $300.00 09/03/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947392
Principal investigator 1 ModernaTX, Inc. $532.00 09/03/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947396
Principal investigator 1 ModernaTX, Inc. $181.94 09/03/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947402
Principal investigator 1 ModernaTX, Inc. $66.50 09/03/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947434
Principal investigator 1 ModernaTX, Inc. $900.00 08/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947384
Principal investigator 1 ModernaTX, Inc. $237.12 08/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002657
Principal investigator 1 ModernaTX, Inc. $300.00 07/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947404
Principal investigator 1 ModernaTX, Inc. $197.60 06/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002675
Principal investigator 1 ModernaTX, Inc. $14,152.84 06/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002697
Principal investigator 1 ModernaTX, Inc. $250.00 06/20/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002671
Principal investigator 1 ModernaTX, Inc. $800.00 06/20/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002679
Principal investigator 1 ModernaTX, Inc. $20,321.39 06/18/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002685
Principal investigator 1 ModernaTX, Inc. $20,155.20 05/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002653
Principal investigator 1 ModernaTX, Inc. $28,275.42 05/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002687
Principal investigator 1 ModernaTX, Inc. $77,826.60 05/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002689
Principal investigator 1 ModernaTX, Inc. $250.00 05/07/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947406
Principal investigator 1 ModernaTX, Inc. $300.00 05/07/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947418
Principal investigator 1 ModernaTX, Inc. $1,000.00 04/30/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002665
Principal investigator 1 ModernaTX, Inc. $22,322.70 04/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002659
Principal investigator 1 ModernaTX, Inc. $26,517.92 04/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002699
Principal investigator 1 ModernaTX, Inc. $30,265.90 04/28/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002701
Principal investigator 1 ModernaTX, Inc. $391.14 03/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002651
Principal investigator 1 ModernaTX, Inc. $13,835.84 03/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002667
Principal investigator 1 ModernaTX, Inc. $24,779.04 03/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002683
Principal investigator 1 ModernaTX, Inc. $23,810.88 03/24/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002695
Principal investigator 1 ModernaTX, Inc. $1,335.26 03/10/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947420
Principal investigator 1 ModernaTX, Inc. $27,051.44 02/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002647
Principal investigator 1 ModernaTX, Inc. $14,881.80 02/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002681
Principal investigator 1 ModernaTX, Inc. $47,993.07 02/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002693
Principal investigator 1 ModernaTX, Inc. $56,544.19 01/30/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947408
Principal investigator 1 ModernaTX, Inc. $300.00 01/30/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002655
Principal investigator 1 ModernaTX, Inc. $20,028.90 01/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 No dispute reported 06/30/2026 1252947428
Principal investigator 1 ModernaTX, Inc. $29,763.60 01/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002649
Principal investigator 1 ModernaTX, Inc. $14,268.21 01/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002661
Principal investigator 1 ModernaTX, Inc. $8,475.04 01/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002663
Principal investigator 1 ModernaTX, Inc. $17,092.40 01/27/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002673
Principal investigator 1 ModernaTX, Inc. $3,978.00 01/08/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002677
Principal investigator 1 ModernaTX, Inc. $100.00 01/03/2025 Non-covered Recipient Entity
DELRICHT RESEARCH
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age No dispute reported 06/30/2026 1253002691